Rank | Gene Set | Z-score |
---|---|---|
1 | ribosomal small subunit assembly (GO:0000028) | 6.37253691 |
2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.78646000 |
3 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.78646000 |
4 | platelet dense granule organization (GO:0060155) | 5.76341782 |
5 | aggressive behavior (GO:0002118) | 5.69100127 |
6 | lymphoid progenitor cell differentiation (GO:0002320) | 5.62653704 |
7 | definitive hemopoiesis (GO:0060216) | 5.57243884 |
8 | negative regulation of granulocyte differentiation (GO:0030853) | 5.16673608 |
9 | blood vessel maturation (GO:0001955) | 5.14992119 |
10 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.99845530 |
11 | viral transcription (GO:0019083) | 4.79229396 |
12 | DNA deamination (GO:0045006) | 4.70879157 |
13 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.58167535 |
14 | translational termination (GO:0006415) | 4.56177581 |
15 | thrombin receptor signaling pathway (GO:0070493) | 4.51008061 |
16 | lymph vessel development (GO:0001945) | 4.50765697 |
17 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.50735341 |
18 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.37467514 |
19 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.19002584 |
20 | Peyers patch development (GO:0048541) | 4.09433940 |
21 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.09433940 |
22 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 4.07927600 |
23 | valine metabolic process (GO:0006573) | 4.06965727 |
24 | regulation of female receptivity (GO:0045924) | 4.06779332 |
25 | megakaryocyte development (GO:0035855) | 3.99433466 |
26 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.97020953 |
27 | translational elongation (GO:0006414) | 3.93936131 |
28 | secretory granule organization (GO:0033363) | 3.92070315 |
29 | cotranslational protein targeting to membrane (GO:0006613) | 3.86521850 |
30 | female mating behavior (GO:0060180) | 3.82799921 |
31 | protein targeting to ER (GO:0045047) | 3.82425917 |
32 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.81500560 |
33 | seminiferous tubule development (GO:0072520) | 3.81239690 |
34 | cellular response to exogenous dsRNA (GO:0071360) | 3.80516708 |
35 | positive regulation of B cell differentiation (GO:0045579) | 3.72876887 |
36 | hyperosmotic salinity response (GO:0042538) | 3.69033048 |
37 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.66163821 |
38 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.65504134 |
39 | response to interferon-beta (GO:0035456) | 3.65190245 |
40 | histamine transport (GO:0051608) | 3.64492051 |
41 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.63748556 |
42 | protein localization to endoplasmic reticulum (GO:0070972) | 3.58414913 |
43 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 3.57571859 |
44 | autophagic vacuole fusion (GO:0000046) | 3.57265326 |
45 | negative regulation of blood vessel endothelial cell migration (GO:0043537) | 3.53817681 |
46 | fucose catabolic process (GO:0019317) | 3.53483074 |
47 | L-fucose metabolic process (GO:0042354) | 3.53483074 |
48 | L-fucose catabolic process (GO:0042355) | 3.53483074 |
49 | negative regulation of phagocytosis (GO:0050765) | 3.53246755 |
50 | viral life cycle (GO:0019058) | 3.51497914 |
51 | histamine secretion (GO:0001821) | 3.49452405 |
52 | ribosomal small subunit biogenesis (GO:0042274) | 3.46818655 |
53 | regulation of B cell differentiation (GO:0045577) | 3.46589760 |
54 | cellular hyperosmotic response (GO:0071474) | 3.46525267 |
55 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.45403135 |
56 | negative regulation of B cell apoptotic process (GO:0002903) | 3.43203354 |
57 | regulation of granulocyte differentiation (GO:0030852) | 3.42585776 |
58 | negative regulation of macrophage differentiation (GO:0045650) | 3.42561773 |
59 | response to interferon-alpha (GO:0035455) | 3.41932141 |
60 | regulation of cell migration involved in sprouting angiogenesis (GO:0090049) | 3.40622685 |
61 | mast cell activation (GO:0045576) | 3.40164886 |
62 | * endothelium development (GO:0003158) | 3.37956246 |
63 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.32386665 |
64 | cellular protein complex disassembly (GO:0043624) | 3.28370917 |
65 | endothelial tube morphogenesis (GO:0061154) | 3.23188963 |
66 | morphogenesis of an endothelium (GO:0003159) | 3.23188963 |
67 | tyrosine phosphorylation of STAT protein (GO:0007260) | 3.23011039 |
68 | DNA strand elongation (GO:0022616) | 3.20595682 |
69 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.20552836 |
70 | maturation of SSU-rRNA (GO:0030490) | 3.19725979 |
71 | positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552) | 3.17872596 |
72 | positive thymic T cell selection (GO:0045059) | 3.16642342 |
73 | mature B cell differentiation involved in immune response (GO:0002313) | 3.15821048 |
74 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.15763620 |
75 | macrophage differentiation (GO:0030225) | 3.11675505 |
76 | telomere maintenance via recombination (GO:0000722) | 3.09561401 |
77 | arginine catabolic process (GO:0006527) | 3.08012342 |
78 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.07822840 |
79 | regulation of B cell apoptotic process (GO:0002902) | 3.03924342 |
80 | negative regulation of smooth muscle cell proliferation (GO:0048662) | 3.03881694 |
81 | positive regulation of lipid kinase activity (GO:0090218) | 3.03043318 |
82 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.01914888 |
83 | DNA unwinding involved in DNA replication (GO:0006268) | 3.01502364 |
84 | response to vitamin E (GO:0033197) | 3.00935421 |
85 | embryonic hemopoiesis (GO:0035162) | 3.00503254 |
86 | venous blood vessel morphogenesis (GO:0048845) | 3.00348598 |
87 | necroptotic process (GO:0070266) | 2.99391227 |
88 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.98567987 |
89 | cellular response to interferon-beta (GO:0035458) | 2.95788028 |
90 | T cell homeostasis (GO:0043029) | 2.95230833 |
91 | triglyceride catabolic process (GO:0019433) | 2.94265717 |
92 | * positive regulation of vasculogenesis (GO:2001214) | 2.94122009 |
93 | translational initiation (GO:0006413) | 2.94051584 |
94 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.92503961 |
95 | protein complex disassembly (GO:0043241) | 2.90579853 |
96 | mast cell degranulation (GO:0043303) | 2.89060134 |
97 | mast cell activation involved in immune response (GO:0002279) | 2.89060134 |
98 | pinocytosis (GO:0006907) | 2.88670857 |
99 | positive regulation of lamellipodium assembly (GO:0010592) | 2.85304990 |
100 | * angiogenesis involved in wound healing (GO:0060055) | 2.84934436 |
101 | regulation of erythrocyte differentiation (GO:0045646) | 2.84204356 |
102 | branched-chain amino acid metabolic process (GO:0009081) | 2.83634411 |
103 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.83225664 |
104 | positive regulation of glomerulus development (GO:0090193) | 2.82646816 |
105 | sprouting angiogenesis (GO:0002040) | 2.81903844 |
106 | regulation of urine volume (GO:0035809) | 2.81516594 |
107 | protein kinase C signaling (GO:0070528) | 2.80267196 |
108 | positive regulation of respiratory burst (GO:0060267) | 2.78784209 |
109 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.77726404 |
110 | regulation of necroptotic process (GO:0060544) | 2.76529123 |
111 | mitotic recombination (GO:0006312) | 2.76171329 |
112 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.76104968 |
113 | interkinetic nuclear migration (GO:0022027) | 2.75281076 |
114 | organelle membrane fusion (GO:0090174) | 2.74725066 |
115 | basement membrane organization (GO:0071711) | 2.73834603 |
116 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.73381894 |
117 | heparin biosynthetic process (GO:0030210) | 2.72645460 |
118 | heparin metabolic process (GO:0030202) | 2.72645460 |
119 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.71710077 |
120 | leukocyte homeostasis (GO:0001776) | 2.69865006 |
121 | response to protozoan (GO:0001562) | 2.69757380 |
122 | positive regulation of antigen processing and presentation (GO:0002579) | 2.69369311 |
123 | positive regulation of urine volume (GO:0035810) | 2.69245623 |
124 | regulation of antigen processing and presentation (GO:0002577) | 2.68874190 |
125 | regulation of respiratory burst (GO:0060263) | 2.68756514 |
126 | purine-containing compound salvage (GO:0043101) | 2.68425361 |
127 | positive regulation of granulocyte differentiation (GO:0030854) | 2.68339504 |
128 | macromolecular complex disassembly (GO:0032984) | 2.67212079 |
129 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.66674833 |
130 | response to UV-B (GO:0010224) | 2.66527808 |
131 | phagocytosis, engulfment (GO:0006911) | 2.65968693 |
132 | lymph node development (GO:0048535) | 2.65872078 |
133 | protein targeting to membrane (GO:0006612) | 2.64873422 |
134 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.64241394 |
135 | telomere maintenance via telomere lengthening (GO:0010833) | 2.64098518 |
136 | endosome to melanosome transport (GO:0035646) | 2.63182290 |
137 | endosome to pigment granule transport (GO:0043485) | 2.63182290 |
138 | DNA replication initiation (GO:0006270) | 2.63162270 |
139 | growth hormone receptor signaling pathway (GO:0060396) | 2.63004576 |
140 | hyperosmotic response (GO:0006972) | 2.62845217 |
141 | phospholipid scrambling (GO:0017121) | 2.61211620 |
142 | cGMP biosynthetic process (GO:0006182) | 2.61124392 |
143 | regulation of sarcomere organization (GO:0060297) | 2.60765441 |
144 | regulation of necrotic cell death (GO:0010939) | 2.60732792 |
145 | defense response to protozoan (GO:0042832) | 2.59981883 |
146 | immunoglobulin mediated immune response (GO:0016064) | 2.59964478 |
147 | ovulation from ovarian follicle (GO:0001542) | 2.59568619 |
148 | regulation of penile erection (GO:0060405) | 2.59506427 |
149 | deoxyribonucleotide catabolic process (GO:0009264) | 2.59030299 |
150 | negative regulation of stress fiber assembly (GO:0051497) | 2.58230379 |
151 | regulation of skeletal muscle contraction (GO:0014819) | 2.56782650 |
152 | purine nucleotide salvage (GO:0032261) | 2.56144363 |
153 | dosage compensation (GO:0007549) | 2.53615802 |
154 | nitric oxide mediated signal transduction (GO:0007263) | 2.53326139 |
155 | 2-oxoglutarate metabolic process (GO:0006103) | 2.52808465 |
156 | regulation of germinal center formation (GO:0002634) | 2.52305106 |
157 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.52050791 |
158 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.51239402 |
159 | deoxyribose phosphate catabolic process (GO:0046386) | 2.50199945 |
160 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.49803856 |
161 | lymphangiogenesis (GO:0001946) | 2.48745726 |
162 | positive regulation of prostaglandin secretion (GO:0032308) | 2.48404971 |
163 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.47747476 |
164 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.47747476 |
165 | * regulation of vasculogenesis (GO:2001212) | 2.47613839 |
166 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.46800456 |
167 | positive regulation of digestive system process (GO:0060456) | 2.45114513 |
168 | short-chain fatty acid metabolic process (GO:0046459) | 2.44114024 |
169 | establishment of endothelial barrier (GO:0061028) | 2.44073745 |
170 | mature B cell differentiation (GO:0002335) | 2.41963927 |
171 | regulation of histone phosphorylation (GO:0033127) | 2.40993037 |
172 | negative regulation of endothelial cell migration (GO:0010596) | 2.40880712 |
173 | neutral lipid catabolic process (GO:0046461) | 2.38186457 |
174 | acylglycerol catabolic process (GO:0046464) | 2.38186457 |
175 | grooming behavior (GO:0007625) | 2.36256234 |
176 | maternal behavior (GO:0042711) | 2.35678481 |
177 | B cell mediated immunity (GO:0019724) | 2.34789248 |
178 | regulation of endothelial cell differentiation (GO:0045601) | 2.34048071 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.87861674 |
2 | SCL_19346495_ChIP-Seq_HPC-7_Human | 5.35133915 |
3 | GATA1_22025678_ChIP-Seq_K562_Human | 4.05627729 |
4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.94327264 |
5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.65306837 |
6 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.51134369 |
7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.43709004 |
8 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.17380289 |
9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.94736592 |
10 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.92005839 |
11 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.91115190 |
12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.83433087 |
13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.80811204 |
14 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.71663758 |
15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.62946143 |
16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.60579502 |
17 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.60017073 |
18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.53850283 |
19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.49416626 |
20 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.48181393 |
21 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.47588633 |
22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.45776097 |
23 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.42409128 |
24 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.27153936 |
25 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.23822960 |
26 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.20555027 |
27 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.19715513 |
28 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.19606708 |
29 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.19124988 |
30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.07226616 |
31 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.05677839 |
32 | MYC_22102868_ChIP-Seq_BL_Human | 2.04903479 |
33 | GATA1_19941826_ChIP-Seq_K562_Human | 2.01055030 |
34 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.98485854 |
35 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.93824936 |
36 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.91882489 |
37 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.91259103 |
38 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.91002609 |
39 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89826661 |
40 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.88926492 |
41 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82695962 |
42 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.80843729 |
43 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.80005570 |
44 | MYB_26560356_Chip-Seq_TH2_Human | 1.79820624 |
45 | MAF_26560356_Chip-Seq_TH1_Human | 1.79253412 |
46 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.76639585 |
47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.74842621 |
48 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.74357310 |
49 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.73983223 |
50 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.73482587 |
51 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.73307567 |
52 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.72669242 |
53 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.71684906 |
54 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.70269029 |
55 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.69600311 |
56 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.64424711 |
57 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.62461804 |
58 | SPI1_23127762_ChIP-Seq_K562_Human | 1.55552187 |
59 | MYB_26560356_Chip-Seq_TH1_Human | 1.54818321 |
60 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.51362292 |
61 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.50471592 |
62 | UTX_26944678_Chip-Seq_JUKART_Human | 1.49499953 |
63 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.45189697 |
64 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.43482283 |
65 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.43455436 |
66 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39067881 |
67 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.38523804 |
68 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.35910638 |
69 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.35186346 |
70 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.33696309 |
71 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.30240368 |
72 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.27352384 |
73 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.27194010 |
74 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.26955455 |
75 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26851285 |
76 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.25843368 |
77 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.24425317 |
78 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.24137029 |
79 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.23380029 |
80 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.22435079 |
81 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.21234466 |
82 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.21092890 |
83 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.20298095 |
84 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17178681 |
85 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.16543950 |
86 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13046802 |
87 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.12447238 |
88 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.12197679 |
89 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.11065844 |
90 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.10639965 |
91 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.09997919 |
92 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09937395 |
93 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.07033569 |
94 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.06345863 |
95 | P68_20966046_ChIP-Seq_HELA_Human | 1.04709541 |
96 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.04382004 |
97 | P300_27268052_Chip-Seq_Bcells_Human | 1.02817102 |
98 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.02746958 |
99 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.02132363 |
100 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.01617431 |
101 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.01223375 |
102 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.01188895 |
103 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.00158635 |
104 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.99378829 |
105 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97229179 |
106 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.96351964 |
107 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.96027119 |
108 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.95727941 |
109 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.95727941 |
110 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95515012 |
111 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.95165896 |
112 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.95097321 |
113 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94629257 |
114 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.94346091 |
115 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.93794554 |
116 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.92543856 |
117 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.91978076 |
118 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.90970176 |
119 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89613006 |
120 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.89124046 |
121 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.88299732 |
122 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.87750410 |
123 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.87570452 |
124 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.86552142 |
125 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.86325288 |
126 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.85415410 |
127 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.84790354 |
128 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82874502 |
129 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.82385196 |
130 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.82290479 |
131 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.82142537 |
132 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.82080278 |
133 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81746260 |
134 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.81736089 |
135 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.80955600 |
136 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.80909794 |
137 | MAF_26560356_Chip-Seq_TH2_Human | 0.79760682 |
138 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.78803039 |
139 | GATA3_26560356_Chip-Seq_TH2_Human | 0.78071455 |
140 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.77708354 |
141 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.77147921 |
142 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.76949081 |
143 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.76771123 |
144 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.75747617 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002396_abnormal_hematopoietic_system | 5.36230069 |
2 | MP0010368_abnormal_lymphatic_system | 4.50277095 |
3 | MP0001879_abnormal_lymphatic_vessel | 3.98573071 |
4 | MP0005670_abnormal_white_adipose | 3.38460466 |
5 | MP0006054_spinal_hemorrhage | 3.20979762 |
6 | MP0004808_abnormal_hematopoietic_stem | 2.84278060 |
7 | MP0004147_increased_porphyrin_level | 2.81767276 |
8 | MP0003724_increased_susceptibility_to | 2.78305360 |
9 | MP0003828_pulmonary_edema | 2.65486893 |
10 | MP0000013_abnormal_adipose_tissue | 2.58987143 |
11 | MP0000465_gastrointestinal_hemorrhage | 2.47095591 |
12 | MP0005167_abnormal_blood-brain_barrier | 2.46333606 |
13 | MP0001835_abnormal_antigen_presentation | 2.37596201 |
14 | MP0005397_hematopoietic_system_phenotyp | 2.34493660 |
15 | MP0001545_abnormal_hematopoietic_system | 2.34493660 |
16 | MP0004272_abnormal_basement_membrane | 2.34186921 |
17 | MP0009785_altered_susceptibility_to | 2.24885337 |
18 | MP0009379_abnormal_foot_pigmentation | 2.23179721 |
19 | MP0005174_abnormal_tail_pigmentation | 2.04001549 |
20 | MP0000343_altered_response_to | 1.97737669 |
21 | MP0005084_abnormal_gallbladder_morpholo | 1.92328116 |
22 | MP0002166_altered_tumor_susceptibility | 1.90251132 |
23 | MP0005464_abnormal_platelet_physiology | 1.89146046 |
24 | MP0008007_abnormal_cellular_replicative | 1.84413716 |
25 | MP0005666_abnormal_adipose_tissue | 1.83993288 |
26 | MP0002138_abnormal_hepatobiliary_system | 1.83382438 |
27 | MP0005375_adipose_tissue_phenotype | 1.77677517 |
28 | MP0004084_abnormal_cardiac_muscle | 1.73785022 |
29 | MP0000685_abnormal_immune_system | 1.71847787 |
30 | MP0009278_abnormal_bone_marrow | 1.71509821 |
31 | MP0009697_abnormal_copulation | 1.69608278 |
32 | MP0000003_abnormal_adipose_tissue | 1.68485098 |
33 | MP0005025_abnormal_response_to | 1.64285330 |
34 | MP0008438_abnormal_cutaneous_collagen | 1.61904605 |
35 | MP0002148_abnormal_hypersensitivity_rea | 1.61121942 |
36 | MP0005409_darkened_coat_color | 1.56650700 |
37 | MP0004130_abnormal_muscle_cell | 1.51910900 |
38 | MP0001188_hyperpigmentation | 1.47872732 |
39 | MP0003279_aneurysm | 1.46446779 |
40 | MP0003763_abnormal_thymus_physiology | 1.46104635 |
41 | MP0002420_abnormal_adaptive_immunity | 1.45140310 |
42 | MP0005075_abnormal_melanosome_morpholog | 1.44616787 |
43 | MP0000751_myopathy | 1.44374227 |
44 | MP0002419_abnormal_innate_immunity | 1.44356998 |
45 | * MP0002398_abnormal_bone_marrow | 1.42888786 |
46 | MP0000490_abnormal_crypts_of | 1.42557747 |
47 | MP0001819_abnormal_immune_cell | 1.42077118 |
48 | MP0001853_heart_inflammation | 1.40646675 |
49 | MP0005671_abnormal_response_to | 1.39811876 |
50 | MP0002006_tumorigenesis | 1.38765179 |
51 | MP0010155_abnormal_intestine_physiology | 1.34752663 |
52 | MP0003567_abnormal_fetal_cardiomyocyte | 1.33346484 |
53 | MP0005503_abnormal_tendon_morphology | 1.33238776 |
54 | MP0005535_abnormal_body_temperature | 1.32873805 |
55 | MP0006036_abnormal_mitochondrial_physio | 1.32427572 |
56 | MP0002452_abnormal_antigen_presenting | 1.31754350 |
57 | MP0002095_abnormal_skin_pigmentation | 1.31442997 |
58 | MP0003806_abnormal_nucleotide_metabolis | 1.28777403 |
59 | MP0003191_abnormal_cellular_cholesterol | 1.28392940 |
60 | MP0002723_abnormal_immune_serum | 1.27682145 |
61 | MP0000230_abnormal_systemic_arterial | 1.26876674 |
62 | MP0005646_abnormal_pituitary_gland | 1.24199250 |
63 | MP0000249_abnormal_blood_vessel | 1.21086754 |
64 | MP0003943_abnormal_hepatobiliary_system | 1.19484296 |
65 | MP0001800_abnormal_humoral_immune | 1.19386836 |
66 | MP0000767_abnormal_smooth_muscle | 1.18836306 |
67 | MP0001873_stomach_inflammation | 1.18740489 |
68 | MP0003300_gastrointestinal_ulcer | 1.18096127 |
69 | * MP0002429_abnormal_blood_cell | 1.17814363 |
70 | MP0005000_abnormal_immune_tolerance | 1.16590076 |
71 | MP0002971_abnormal_brown_adipose | 1.16250297 |
72 | * MP0000716_abnormal_immune_system | 1.14699212 |
73 | MP0001958_emphysema | 1.13305103 |
74 | MP0004145_abnormal_muscle_electrophysio | 1.13130897 |
75 | MP0002722_abnormal_immune_system | 1.12418035 |
76 | MP0002127_abnormal_cardiovascular_syste | 1.12255512 |
77 | MP0004782_abnormal_surfactant_physiolog | 1.12120983 |
78 | MP0003075_altered_response_to | 1.11767566 |
79 | MP0005330_cardiomyopathy | 1.11667884 |
80 | * MP0000689_abnormal_spleen_morphology | 1.09775551 |
81 | MP0004215_abnormal_myocardial_fiber | 1.07843326 |
82 | MP0004484_altered_response_of | 1.05900666 |
83 | MP0000015_abnormal_ear_pigmentation | 1.03394040 |
84 | MP0003436_decreased_susceptibility_to | 1.01351813 |
85 | MP0005165_increased_susceptibility_to | 1.00482272 |
86 | MP0002405_respiratory_system_inflammati | 0.98325134 |
87 | MP0005385_cardiovascular_system_phenoty | 0.97733166 |
88 | MP0001544_abnormal_cardiovascular_syste | 0.97733166 |
89 | MP0009333_abnormal_splenocyte_physiolog | 0.96840195 |
90 | MP0009764_decreased_sensitivity_to | 0.96771960 |
91 | MP0006138_congestive_heart_failure | 0.95794041 |
92 | MP0006276_abnormal_autonomic_nervous | 0.95659554 |
93 | MP0005275_abnormal_skin_tensile | 0.94965896 |
94 | MP0003866_abnormal_defecation | 0.94876370 |
95 | MP0010094_abnormal_chromosome_stability | 0.94053790 |
96 | MP0003566_abnormal_cell_adhesion | 0.93470988 |
97 | MP0010630_abnormal_cardiac_muscle | 0.93198032 |
98 | MP0004036_abnormal_muscle_relaxation | 0.92317912 |
99 | MP0002876_abnormal_thyroid_physiology | 0.91076006 |
100 | MP0002332_abnormal_exercise_endurance | 0.89636017 |
101 | MP0003646_muscle_fatigue | 0.89578633 |
102 | MP0009115_abnormal_fat_cell | 0.89542232 |
103 | MP0005595_abnormal_vascular_smooth | 0.89535869 |
104 | MP0000703_abnormal_thymus_morphology | 0.88584244 |
105 | MP0005220_abnormal_exocrine_pancreas | 0.87742663 |
106 | MP0005645_abnormal_hypothalamus_physiol | 0.87271221 |
107 | MP0002933_joint_inflammation | 0.85225851 |
108 | MP0002128_abnormal_blood_circulation | 0.84785788 |
109 | MP0001845_abnormal_inflammatory_respons | 0.83202156 |
110 | MP0000681_abnormal_thyroid_gland | 0.82038440 |
111 | MP0004087_abnormal_muscle_fiber | 0.81599703 |
112 | MP0005334_abnormal_fat_pad | 0.80453620 |
113 | MP0001614_abnormal_blood_vessel | 0.79146302 |
114 | MP0005620_abnormal_muscle_contractility | 0.78803146 |
115 | MP0008469_abnormal_protein_level | 0.78624217 |
116 | MP0002106_abnormal_muscle_physiology | 0.78516165 |
117 | MP0001790_abnormal_immune_system | 0.78038785 |
118 | MP0005387_immune_system_phenotype | 0.78038785 |
119 | MP0002108_abnormal_muscle_morphology | 0.77384390 |
120 | MP0002060_abnormal_skin_morphology | 0.76990911 |
121 | MP0002925_abnormal_cardiovascular_devel | 0.76760700 |
122 | MP0001851_eye_inflammation | 0.76386148 |
123 | MP0003959_abnormal_lean_body | 0.75407613 |
124 | MP0001986_abnormal_taste_sensitivity | 0.74650189 |
125 | MP0002972_abnormal_cardiac_muscle | 0.74288345 |
126 | MP0005390_skeleton_phenotype | 0.73905465 |
127 | MP0005369_muscle_phenotype | 0.73670932 |
128 | MP0000749_muscle_degeneration | 0.72558394 |
129 | MP0002132_abnormal_respiratory_system | 0.71712411 |
130 | MP0003221_abnormal_cardiomyocyte_apopto | 0.71627585 |
131 | * MP0002019_abnormal_tumor_incidence | 0.70034798 |
132 | MP0004085_abnormal_heartbeat | 0.70033539 |
133 | MP0001764_abnormal_homeostasis | 0.69476119 |
134 | MP0003303_peritoneal_inflammation | 0.69224537 |
135 | MP0002877_abnormal_melanocyte_morpholog | 0.68576232 |
136 | MP0001533_abnormal_skeleton_physiology | 0.68293286 |
137 | MP0008775_abnormal_heart_ventricle | 0.67938566 |
138 | MP0003638_abnormal_response/metabolism_ | 0.65959889 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.08363046 |
2 | Thrombocytosis (HP:0001894) | 5.04866214 |
3 | Chronic otitis media (HP:0000389) | 4.64377193 |
4 | Myositis (HP:0100614) | 4.62262719 |
5 | Acute lymphatic leukemia (HP:0006721) | 4.29070938 |
6 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.17008638 |
7 | Abnormal number of erythroid precursors (HP:0012131) | 4.03773783 |
8 | Agammaglobulinemia (HP:0004432) | 3.91347834 |
9 | Muscle fiber splitting (HP:0003555) | 3.86081353 |
10 | Hematochezia (HP:0002573) | 3.85057175 |
11 | Aplastic anemia (HP:0001915) | 3.83468812 |
12 | IgM deficiency (HP:0002850) | 3.78516634 |
13 | Abnormality of the nasal mucosa (HP:0000433) | 3.70420050 |
14 | Acute myeloid leukemia (HP:0004808) | 3.66010118 |
15 | Spontaneous hematomas (HP:0007420) | 3.59205782 |
16 | Reticulocytopenia (HP:0001896) | 3.58336229 |
17 | Exercise-induced myalgia (HP:0003738) | 3.31030722 |
18 | Prolonged bleeding time (HP:0003010) | 3.19304739 |
19 | Reduced antithrombin III activity (HP:0001976) | 3.17792753 |
20 | Distal arthrogryposis (HP:0005684) | 3.02706032 |
21 | Nemaline bodies (HP:0003798) | 2.97690488 |
22 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.97387535 |
23 | Protrusio acetabuli (HP:0003179) | 2.97237155 |
24 | Oligomenorrhea (HP:0000876) | 2.91362710 |
25 | Cerebral palsy (HP:0100021) | 2.90785208 |
26 | Abnormal platelet function (HP:0011869) | 2.86028192 |
27 | Impaired platelet aggregation (HP:0003540) | 2.86028192 |
28 | Increased muscle lipid content (HP:0009058) | 2.83391494 |
29 | Autoimmune hemolytic anemia (HP:0001890) | 2.81468442 |
30 | Ankle contracture (HP:0006466) | 2.72451290 |
31 | Recurrent abscess formation (HP:0002722) | 2.71999578 |
32 | Interstitial pulmonary disease (HP:0006530) | 2.71879767 |
33 | Muscle fiber inclusion bodies (HP:0100299) | 2.69491514 |
34 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.69443673 |
35 | Metaphyseal dysplasia (HP:0100255) | 2.68588887 |
36 | Type I transferrin isoform profile (HP:0003642) | 2.67134281 |
37 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.63383025 |
38 | Stomach cancer (HP:0012126) | 2.63132784 |
39 | Petechiae (HP:0000967) | 2.62459532 |
40 | Hyporeflexia of lower limbs (HP:0002600) | 2.60542686 |
41 | Increased variability in muscle fiber diameter (HP:0003557) | 2.57384778 |
42 | Sudden death (HP:0001699) | 2.56019522 |
43 | Erythema (HP:0010783) | 2.54823079 |
44 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.54030898 |
45 | Rhabdomyolysis (HP:0003201) | 2.53659553 |
46 | Abnormality of T cell physiology (HP:0011840) | 2.52943628 |
47 | Recurrent bronchitis (HP:0002837) | 2.45348443 |
48 | Growth hormone excess (HP:0000845) | 2.44386965 |
49 | Mesangial abnormality (HP:0001966) | 2.44031966 |
50 | Dicarboxylic aciduria (HP:0003215) | 2.38368517 |
51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.38368517 |
52 | Neck muscle weakness (HP:0000467) | 2.38075712 |
53 | Inflammation of the large intestine (HP:0002037) | 2.35515700 |
54 | Abnormal protein glycosylation (HP:0012346) | 2.35364471 |
55 | Abnormal glycosylation (HP:0012345) | 2.35364471 |
56 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.35364471 |
57 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.35364471 |
58 | Panhypogammaglobulinemia (HP:0003139) | 2.33266496 |
59 | Delayed CNS myelination (HP:0002188) | 2.33224488 |
60 | Atrioventricular block (HP:0001678) | 2.33205787 |
61 | Increased intramyocellular lipid droplets (HP:0012240) | 2.32160556 |
62 | Granulocytopenia (HP:0001913) | 2.31290381 |
63 | Polygenic inheritance (HP:0010982) | 2.30940009 |
64 | Gastrointestinal inflammation (HP:0004386) | 2.29732066 |
65 | Muscle stiffness (HP:0003552) | 2.29071309 |
66 | Hypoproteinemia (HP:0003075) | 2.29051133 |
67 | Broad metatarsal (HP:0001783) | 2.28557115 |
68 | Polycythemia (HP:0001901) | 2.26409709 |
69 | Microcytic anemia (HP:0001935) | 2.26304442 |
70 | Cervical subluxation (HP:0003308) | 2.24950834 |
71 | Seborrheic dermatitis (HP:0001051) | 2.24564829 |
72 | Myoglobinuria (HP:0002913) | 2.23001365 |
73 | Areflexia of lower limbs (HP:0002522) | 2.19555275 |
74 | Epistaxis (HP:0000421) | 2.19271199 |
75 | Pallor (HP:0000980) | 2.18727640 |
76 | Orchitis (HP:0100796) | 2.17866844 |
77 | Flat cornea (HP:0007720) | 2.17646453 |
78 | Colitis (HP:0002583) | 2.15920411 |
79 | Nasal polyposis (HP:0100582) | 2.14485141 |
80 | Cellulitis (HP:0100658) | 2.13457609 |
81 | Vertigo (HP:0002321) | 2.12378024 |
82 | Abnormality of the hepatic vasculature (HP:0006707) | 2.11995624 |
83 | Round ear (HP:0100830) | 2.11728133 |
84 | Abnormality of the periventricular white matter (HP:0002518) | 2.11420139 |
85 | Asymmetric septal hypertrophy (HP:0001670) | 2.11263944 |
86 | Increased connective tissue (HP:0009025) | 2.08683285 |
87 | Congenital, generalized hypertrichosis (HP:0004540) | 2.07297737 |
88 | Subaortic stenosis (HP:0001682) | 2.06997826 |
89 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.06997826 |
90 | Papilledema (HP:0001085) | 2.06809764 |
91 | Heart block (HP:0012722) | 2.06244717 |
92 | Autoimmune thrombocytopenia (HP:0001973) | 2.05687113 |
93 | Recurrent bacterial skin infections (HP:0005406) | 2.03857323 |
94 | Hypergammaglobulinemia (HP:0010702) | 2.03615883 |
95 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.03476770 |
96 | Acanthosis nigricans (HP:0000956) | 2.03330553 |
97 | B lymphocytopenia (HP:0010976) | 2.02715480 |
98 | Abnormality of B cell number (HP:0010975) | 2.02715480 |
99 | Type 2 muscle fiber atrophy (HP:0003554) | 2.01737237 |
100 | Albinism (HP:0001022) | 2.01319734 |
101 | Muscle fiber atrophy (HP:0100295) | 2.00088736 |
102 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.99949624 |
103 | Abnormality of alanine metabolism (HP:0010916) | 1.99949624 |
104 | Hyperalaninemia (HP:0003348) | 1.99949624 |
105 | Cerebral aneurysm (HP:0004944) | 1.98835304 |
106 | Recurrent fungal infections (HP:0002841) | 1.97839829 |
107 | Rimmed vacuoles (HP:0003805) | 1.97702232 |
108 | Poikiloderma (HP:0001029) | 1.96962789 |
109 | Ventricular tachycardia (HP:0004756) | 1.96162866 |
110 | Porencephaly (HP:0002132) | 1.95448726 |
111 | Lymphedema (HP:0001004) | 1.94493822 |
112 | Bulbar palsy (HP:0001283) | 1.93193170 |
113 | Increased IgE level (HP:0003212) | 1.92536671 |
114 | Chest pain (HP:0100749) | 1.92226879 |
115 | Lipoatrophy (HP:0100578) | 1.92174225 |
116 | Periorbital edema (HP:0100539) | 1.91839179 |
117 | Stomatitis (HP:0010280) | 1.91639144 |
118 | Hypothermia (HP:0002045) | 1.90991672 |
119 | Bicuspid aortic valve (HP:0001647) | 1.90877857 |
120 | Nonimmune hydrops fetalis (HP:0001790) | 1.89575975 |
121 | Abnormality of the peritoneum (HP:0002585) | 1.88994506 |
122 | EMG: myopathic abnormalities (HP:0003458) | 1.88924017 |
123 | Facial diplegia (HP:0001349) | 1.88737112 |
124 | Type 1 muscle fiber predominance (HP:0003803) | 1.88720120 |
125 | Broad face (HP:0000283) | 1.88687662 |
126 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.88511973 |
127 | Macrocytic anemia (HP:0001972) | 1.88097746 |
128 | Abnormal atrioventricular conduction (HP:0005150) | 1.86463340 |
129 | Chronic obstructive pulmonary disease (HP:0006510) | 1.86058861 |
130 | Obstructive lung disease (HP:0006536) | 1.86058861 |
131 | Spinal cord lesions (HP:0100561) | 1.85566197 |
132 | Syringomyelia (HP:0003396) | 1.85566197 |
133 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.85447737 |
134 | Supraventricular arrhythmia (HP:0005115) | 1.85420276 |
135 | Hypertriglyceridemia (HP:0002155) | 1.85329625 |
136 | Hypertensive crisis (HP:0100735) | 1.84224206 |
137 | Ragged-red muscle fibers (HP:0003200) | 1.82548604 |
138 | Joint stiffness (HP:0001387) | 1.82487954 |
139 | Meningitis (HP:0001287) | 1.82310447 |
140 | Abnormality of the columella (HP:0009929) | 1.82004275 |
141 | J-shaped sella turcica (HP:0002680) | 1.80264466 |
142 | Weak cry (HP:0001612) | 1.79776163 |
143 | Recurrent viral infections (HP:0004429) | 1.79462892 |
144 | Abnormality of the prostate (HP:0008775) | 1.79438255 |
145 | Facial edema (HP:0000282) | 1.79279454 |
146 | Malignant hyperthermia (HP:0002047) | 1.78794524 |
147 | Primary atrial arrhythmia (HP:0001692) | 1.78727865 |
148 | Difficulty running (HP:0009046) | 1.78292219 |
149 | Pigmentary retinal degeneration (HP:0001146) | 1.78070607 |
150 | Myelodysplasia (HP:0002863) | 1.77145148 |
151 | Atrial fibrillation (HP:0005110) | 1.77079780 |
152 | Severe visual impairment (HP:0001141) | 1.76239252 |
153 | High pitched voice (HP:0001620) | 1.76170275 |
154 | Adactyly (HP:0009776) | 1.75311508 |
155 | Large hands (HP:0001176) | 1.73643488 |
156 | Arterial thrombosis (HP:0004420) | 1.71651952 |
157 | Hemoptysis (HP:0002105) | 1.71593066 |
158 | Entropion (HP:0000621) | 1.71080892 |
159 | Portal hypertension (HP:0001409) | 1.70608266 |
160 | Fatigue (HP:0012378) | 1.69854097 |
161 | Bruising susceptibility (HP:0000978) | 1.69160646 |
162 | Lymphoma (HP:0002665) | 1.67479348 |
163 | Myotonia (HP:0002486) | 1.67264208 |
164 | Lymphangioma (HP:0100764) | 1.66446853 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TIE1 | 5.38137122 |
2 | FLT3 | 5.33519329 |
3 | KIT | 4.69324813 |
4 | KDR | 3.52114473 |
5 | TGFBR1 | 3.25507617 |
6 | TGFBR2 | 2.94538203 |
7 | TEC | 2.79107015 |
8 | CSF1R | 2.58554751 |
9 | ACVR1B | 2.26649984 |
10 | TNIK | 2.25260626 |
11 | WEE1 | 2.06750371 |
12 | MAP4K1 | 2.06620666 |
13 | MAP2K3 | 2.04614672 |
14 | BTK | 1.96418142 |
15 | PIM2 | 1.82320644 |
16 | EEF2K | 1.75858793 |
17 | NME2 | 1.75796217 |
18 | BRSK2 | 1.71420450 |
19 | INSRR | 1.52917334 |
20 | MAPKAPK3 | 1.51154058 |
21 | MAP4K2 | 1.50826355 |
22 | MAP3K6 | 1.48203002 |
23 | MYLK | 1.46236237 |
24 | STK16 | 1.44644909 |
25 | OBSCN | 1.36234789 |
26 | FES | 1.30090287 |
27 | VRK2 | 1.29062498 |
28 | BCKDK | 1.28595470 |
29 | IRAK4 | 1.27903106 |
30 | FER | 1.27617181 |
31 | MAP3K12 | 1.26920332 |
32 | SCYL2 | 1.25708362 |
33 | TNK2 | 1.23655455 |
34 | CDK19 | 1.23191691 |
35 | RIPK1 | 1.21844502 |
36 | PINK1 | 1.20197358 |
37 | ZAP70 | 1.19323215 |
38 | VRK1 | 1.15631024 |
39 | TBK1 | 1.15070431 |
40 | NLK | 1.13629574 |
41 | MATK | 1.11420381 |
42 | CDK8 | 1.09212444 |
43 | PKN2 | 1.07416366 |
44 | MAP3K13 | 1.04741056 |
45 | RPS6KB2 | 1.03986541 |
46 | ADRBK2 | 1.03124004 |
47 | CAMKK2 | 0.98710147 |
48 | DAPK2 | 0.98528469 |
49 | LRRK2 | 0.96893199 |
50 | MAPKAPK5 | 0.96718237 |
51 | CCNB1 | 0.95608047 |
52 | BMPR1B | 0.94822016 |
53 | ITK | 0.92046406 |
54 | ERN1 | 0.89687614 |
55 | PAK4 | 0.89521094 |
56 | SYK | 0.83961020 |
57 | JAK3 | 0.79691763 |
58 | GRK6 | 0.79673948 |
59 | PRKG2 | 0.77740088 |
60 | MAPK7 | 0.72252140 |
61 | TSSK6 | 0.71669359 |
62 | DYRK3 | 0.70139135 |
63 | TESK2 | 0.68680790 |
64 | MAPK12 | 0.67466314 |
65 | MKNK1 | 0.66114894 |
66 | CDK9 | 0.64354421 |
67 | MAP3K1 | 0.63510261 |
68 | TTN | 0.63331993 |
69 | MUSK | 0.63244249 |
70 | LYN | 0.61750676 |
71 | TYK2 | 0.59209625 |
72 | MAPK4 | 0.59070787 |
73 | TRPM7 | 0.58340859 |
74 | CAMK1 | 0.58199810 |
75 | MAP3K3 | 0.57837674 |
76 | MAP3K11 | 0.57609299 |
77 | PRKCQ | 0.56963073 |
78 | MAPK3 | 0.56419556 |
79 | PDK2 | 0.55702811 |
80 | DAPK1 | 0.54416030 |
81 | PTK2B | 0.54167480 |
82 | IKBKE | 0.51242563 |
83 | RPS6KA4 | 0.50618741 |
84 | GRK5 | 0.49170250 |
85 | MAP3K14 | 0.48982568 |
86 | PRKD1 | 0.47865920 |
87 | CDK7 | 0.47065088 |
88 | ADRBK1 | 0.46413652 |
89 | * LCK | 0.46201876 |
90 | ILK | 0.46042118 |
91 | CLK1 | 0.45482994 |
92 | PRKD2 | 0.45406719 |
93 | BRSK1 | 0.45070945 |
94 | HCK | 0.44495233 |
95 | ABL2 | 0.44009052 |
96 | PIM1 | 0.43496435 |
97 | PAK2 | 0.43175417 |
98 | GRK1 | 0.41023950 |
99 | RPS6KL1 | 0.41014584 |
100 | RPS6KC1 | 0.41014584 |
101 | CSK | 0.38716151 |
102 | ZAK | 0.37253471 |
103 | DYRK1B | 0.37074389 |
104 | TXK | 0.36720292 |
105 | PIK3CA | 0.36203969 |
106 | HIPK2 | 0.34974977 |
107 | MAP2K6 | 0.34080454 |
108 | DAPK3 | 0.33116546 |
109 | PIK3CG | 0.32914836 |
110 | TRIB3 | 0.32825481 |
111 | MAP2K2 | 0.32298308 |
112 | IKBKB | 0.31829371 |
113 | ATR | 0.29865803 |
114 | MAPK11 | 0.28932170 |
115 | CDK6 | 0.28626251 |
116 | STK10 | 0.28204552 |
117 | MAP3K7 | 0.27109033 |
118 | RPS6KA5 | 0.26919231 |
119 | MARK2 | 0.26807757 |
120 | EIF2AK3 | 0.26705999 |
121 | PKN1 | 0.26656150 |
122 | * IGF1R | 0.26187267 |
123 | RPS6KA6 | 0.26155191 |
124 | ABL1 | 0.26020644 |
125 | EIF2AK2 | 0.26005306 |
126 | CDC7 | 0.25846553 |
127 | JAK2 | 0.24795913 |
128 | FRK | 0.24316360 |
129 | IRAK1 | 0.23969147 |
130 | TAOK3 | 0.23629167 |
131 | PRKAA2 | 0.23601304 |
132 | MAP2K4 | 0.23504737 |
133 | NUAK1 | 0.23091517 |
134 | YES1 | 0.22745499 |
135 | BUB1 | 0.22082141 |
136 | CDK4 | 0.21933841 |
137 | TAOK2 | 0.21414683 |
138 | PTK6 | 0.21099937 |
139 | CAMK4 | 0.20476404 |
140 | IRAK3 | 0.20000188 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 4.42125895 |
2 | Asthma_Homo sapiens_hsa05310 | 4.02521672 |
3 | Ribosome_Homo sapiens_hsa03010 | 3.74573005 |
4 | Allograft rejection_Homo sapiens_hsa05330 | 2.86677040 |
5 | Mismatch repair_Homo sapiens_hsa03430 | 2.65865514 |
6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.49673297 |
7 | Base excision repair_Homo sapiens_hsa03410 | 2.37625800 |
8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.37446511 |
9 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.10440857 |
10 | Homologous recombination_Homo sapiens_hsa03440 | 1.97210119 |
11 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.96647177 |
12 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.87827551 |
13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.86455181 |
14 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.85552181 |
15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.74957021 |
16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.71294768 |
17 | Renin secretion_Homo sapiens_hsa04924 | 1.70180424 |
18 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.68864872 |
19 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.65562028 |
20 | Platelet activation_Homo sapiens_hsa04611 | 1.61622780 |
21 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.61474386 |
22 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.57698872 |
23 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.53868110 |
24 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.51087651 |
25 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.50588948 |
26 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.50224683 |
27 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.49786381 |
28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.47865817 |
29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.47593113 |
30 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.47493556 |
31 | Malaria_Homo sapiens_hsa05144 | 1.42380771 |
32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.41774283 |
33 | Pertussis_Homo sapiens_hsa05133 | 1.41099568 |
34 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.39992673 |
35 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.38490895 |
36 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.38464630 |
37 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.37200835 |
38 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.36436596 |
39 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.31772040 |
40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.29623716 |
41 | Legionellosis_Homo sapiens_hsa05134 | 1.28443261 |
42 | Thyroid cancer_Homo sapiens_hsa05216 | 1.28064132 |
43 | Measles_Homo sapiens_hsa05162 | 1.28048795 |
44 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.28012673 |
45 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.26241535 |
46 | Spliceosome_Homo sapiens_hsa03040 | 1.24617854 |
47 | Peroxisome_Homo sapiens_hsa04146 | 1.24298108 |
48 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.24162785 |
49 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.21693060 |
50 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.19521614 |
51 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.18441328 |
52 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.17796599 |
53 | Other glycan degradation_Homo sapiens_hsa00511 | 1.17160561 |
54 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.16480888 |
55 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.16310093 |
56 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.16180592 |
57 | Cell cycle_Homo sapiens_hsa04110 | 1.16159844 |
58 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.15334422 |
59 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.15006764 |
60 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14322059 |
61 | Shigellosis_Homo sapiens_hsa05131 | 1.12445627 |
62 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.08283387 |
63 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.05268884 |
64 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.03245632 |
65 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.02870102 |
66 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.02733511 |
67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.02214048 |
68 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.01820206 |
69 | Focal adhesion_Homo sapiens_hsa04510 | 1.00506875 |
70 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.97748513 |
71 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.97576069 |
72 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.96792880 |
73 | Viral myocarditis_Homo sapiens_hsa05416 | 0.96132904 |
74 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.95636790 |
75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94541866 |
76 | Influenza A_Homo sapiens_hsa05164 | 0.92520878 |
77 | Hepatitis B_Homo sapiens_hsa05161 | 0.90706901 |
78 | Purine metabolism_Homo sapiens_hsa00230 | 0.90523995 |
79 | RNA degradation_Homo sapiens_hsa03018 | 0.89649258 |
80 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.88780079 |
81 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.87636207 |
82 | Salmonella infection_Homo sapiens_hsa05132 | 0.86558101 |
83 | Salivary secretion_Homo sapiens_hsa04970 | 0.86341175 |
84 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.84643429 |
85 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.84138750 |
86 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.82044744 |
87 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.75934297 |
88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75588537 |
89 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.75030271 |
90 | HTLV-I infection_Homo sapiens_hsa05166 | 0.74852373 |
91 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.74789960 |
92 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.74107779 |
93 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.73857421 |
94 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.71925797 |
95 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70866608 |
96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.70677197 |
97 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.70434828 |
98 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.69994985 |
99 | Protein export_Homo sapiens_hsa03060 | 0.66302299 |
100 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.65993022 |
101 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.65598385 |
102 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.65372207 |
103 | Pathways in cancer_Homo sapiens_hsa05200 | 0.65317324 |
104 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65289856 |
105 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.65166651 |
106 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.64906995 |
107 | Apoptosis_Homo sapiens_hsa04210 | 0.64670118 |
108 | Phototransduction_Homo sapiens_hsa04744 | 0.63696352 |
109 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.62655561 |
110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62554243 |
111 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.62285972 |
112 | RNA polymerase_Homo sapiens_hsa03020 | 0.62253474 |
113 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62198823 |
114 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.61173817 |
115 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.60572060 |
116 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59609647 |
117 | Amoebiasis_Homo sapiens_hsa05146 | 0.59296866 |
118 | Olfactory transduction_Homo sapiens_hsa04740 | 0.59120579 |
119 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.59004590 |
120 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57658371 |
121 | Proteasome_Homo sapiens_hsa03050 | 0.57568091 |
122 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.57260410 |
123 | Tuberculosis_Homo sapiens_hsa05152 | 0.57244350 |
124 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57192901 |
125 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56809884 |
126 | Insulin resistance_Homo sapiens_hsa04931 | 0.56634109 |
127 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.55904978 |
128 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.55874648 |
129 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.55416101 |
130 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.54795563 |
131 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.54286268 |
132 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53604279 |
133 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.53245498 |
134 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.53149980 |
135 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.53083511 |
136 | Hepatitis C_Homo sapiens_hsa05160 | 0.51640092 |
137 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.50578025 |
138 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.48856636 |
139 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.45774108 |
140 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.45718365 |
141 | Colorectal cancer_Homo sapiens_hsa05210 | 0.45573714 |
142 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45533891 |
143 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.45415153 |
144 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.43534238 |
145 | Adherens junction_Homo sapiens_hsa04520 | 0.43478207 |
146 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.42234214 |
147 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.41920523 |
148 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41610925 |
149 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.41294725 |
150 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.39986878 |
151 | ABC transporters_Homo sapiens_hsa02010 | 0.39649981 |
152 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.39555783 |
153 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.34104316 |
154 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.33285401 |
155 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.32519071 |
156 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.32484290 |
157 | Circadian entrainment_Homo sapiens_hsa04713 | 0.32019463 |
158 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.30779933 |